New FDA Webinar Series on Substantial Equivalence Predicate Preview Process
The U.S. Food and Drug Administration’s (FDA) Center for Tobacco Products (CTP) has received questions about how companies can improve the quality of their premarket applications under the substantial equivalence (SE) pathway. To help, FDA is launching a three-part
webinar series
on the SE predicate review process.